Bupa

The private medical insurance (PMI) market's two biggest players have seen a rise in the number of complaints escalated to the Financial Ombudsman Service (FOS).

It is clear that medical inflation is having consequences, but what is causing it and what is to be done? Mike Izzard investigates.

Axa PPP has extended its cancer coverage to include the clinically effective prostate cancer drug rejected for the NHS because it is too expensive.

The coming year promises to be a tough one for the private healthcare sector, according to a new report from analyst Laing and Buisson.

Healix has voiced support for the use of open referrals within the private medical insurance (PMI) market but warned that insurers need to be more transparent about the process.

Bupa has launched Bupa Anytime HealthLine, a helpline providing 24 hour, unlimited medical advice and information from a team of GPs and nurses.

Bupa has launched a free iPhone and Android app to enable its international private medical insurance (IPMI) customers to access their policy information from anywhere in the world.

Bupa has reached an agreement with BMI Healthcare to re-introduce patient treatment at all but three of the hospital network's facilities.

Bupa has hit back at claims by doctors that its open referrals process is ‘flawed on several levels' and limits patient choice.

Insurers and charities have urged the government and other party leaders to agree on substantial reforms to the social care system that is causing further damage to the NHS.